Newsroom

Sorted by: Latest

-

Rutherford Energy Ventures Co-Founder Dennis Whyte Appointed as Next CEO of UK Atomic Energy Authority in New Global Fusion Leadership Role

BOSTON--(BUSINESS WIRE)--Rutherford Energy Ventures Co-Founder Dennis Whyte Appointed as Next CEO of UK Atomic Energy Authority in New Global Fusion Leadership Role....
-

Gen Z Spending is Expected to Reach $12 Trillion by 2030. Here's Why That Doesn't Matter as Much as Brands Think

CHICAGO--(BUSINESS WIRE)--The biggest shift in consumer spending isn't generational—it's behavioral. New research from NielsenIQ (NYSE: NIQ) finds consumers across every age group are increasingly making the same calculation: where is a premium worth paying, and where can they save money instead? The result is a growing divide between premium and value products, while traditional middle-market offerings face mounting pressure. The findings come from NIQ's latest global report, A Tale of Two Con...
-

Marti Technologies Launches Ride-Hailing Service in 10 New Cities Across Türkiye

ISTANBUL--(BUSINESS WIRE)--Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT), Türkiye’s leading mobility super app, today announced the launch of its ride-hailing service in 10 additional cities across Türkiye, expanding Marti’s ride-hailing footprint to 30 cities and approximately 85% of Türkiye’s GDP. Marti is expanding its ride-hailing service in response to demand, supply, and growth rates in cities outside Türkiye’s largest city, Istanbul, exceeding expectations. The...
-

BETA Technologies, Inc. Announces Second Quarter 2026 Results

SOUTH BURLINGTON, Vt.--(BUSINESS WIRE)--BETA Technologies, Inc. (NYSE: BETA) (“BETA” or the “Company”), an aerospace and defense company, today announced its financial and operating results for the second quarter ended June 30, 2026. “This quarter showed that the investments made across the business continue to translate into real-world operations and delivered tangible results,” said Kyle Clark, founder and chief executive officer of BETA. “We became the first company to launch operations unde...
-

American Strategic Investment Co. Announces Second Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”), a company that owns a portfolio of commercial real estate located within the five boroughs of New York City, announced today its financial and operating results for the second quarter ended June 30, 2026. Second Quarter 2026 Highlights Revenue was $7.3 million compared to $12.2 million in the second quarter of 2025, primarily related to the disposition of 1140 Avenue of the Americas in the prior...
-

Online Platforms Face Growing Pressure to Strengthen Age Assurance

SUNNYVALE, Calif.--(BUSINESS WIRE)--Consumers back stronger age safeguards, but want privacy: 67% prefer proving eligibility without sharing full personal details....
-

National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results

ALPHARETTA, Ga.--(BUSINESS WIRE)--National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its second quarter 2026 results....
-

ChargerHelp to Unveil 2026 EV Charging Reliability Report at Forth Roadmap

LOS ANGELES--(BUSINESS WIRE)--Attendees at this year's Forth Roadmap Conference in Seattle, Wash., will get their first public look at ChargerHelp's 2026 EV Charging Reliability Report during a special session led by ChargerHelp CEO and co-founder Kameale Terry. Now in its fourth year, the report has expanded significantly in both scope and depth, reflecting the increasing complexity of operating charging infrastructure at scale. Session Information: Reality of EV Charging Recovery: Half a Bill...
-

Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a new collaboration regarding a Phase 1 clinical trial, sponsored by Kupando Therapeutics. Under the agreement, Natera’s Latitude tissue-free assay for molecular residual disease (MRD) detection will be used in Kupando’s clinical trial of its lead immunotherapy candidate, KUP-101. The trial will assess serial circulating tumor DNA (ctDNA) dynamics as part of trea...
-

WisdomTree Reports Monthly Metrics for July 2026

NEW YORK--(BUSINESS WIRE)--WisdomTree today released monthly metrics for July 2026, including assets under management (AUM) and flow data by asset class....